Aurora Cannabis (ACB) Long-Term Debt Repayments (2018 - 2024)
Aurora Cannabis (ACB) reported Long-Term Debt Repayments of -$416624.2 for Q4 2024, up 97.48% year-over-year from -$210966.5 in Q1 2024, and down 10.36% quarter-over-quarter from -$377522.5 in Q3 2024.
Aurora Cannabis (ACB) Long-Term Debt Repayments (2018 - 2024) Analysis & Trends
Aurora Cannabis (ACB) has 5 years of Long-Term Debt Repayments data on file, last reported at -$416624.2 in Q4 2024.
- Long-Term Debt Repayments for Q4 2024 came in at -$416624.2, up 97.48% year-over-year; the trailing twelve-month figure through Dec 2024 was -$21.4 million (up 90.4% YoY), and the FY2023 annual result was -$46.1 million, up 64.31% from the prior year.
- Long-Term Debt Repayments fell to -$416624.2 in Q4 2024 per ACB's latest filing, from -$377522.5 in the prior quarter.
- Over five years, Long-Term Debt Repayments peaked at -$377522.5 in Q3 2024 and troughed at -$114.2 million in Q2 2022.
- A 3-year average of -$39.1 million and a median of -$9.1 million in 2022 frame the typical range for Long-Term Debt Repayments.
- The sharpest annual moves came in 2023 and 2024: Long-Term Debt Repayments surged 99.66% in 2023, then advanced 1.92% in 2024.
- A 3-year view of Long-Term Debt Repayments shows it stood at -$94.8 million in 2022, then soared by 82.54% to -$16.6 million in 2023, then jumped by 97.48% to -$416624.2 in 2024.
- Business Quant data shows ACB's Long-Term Debt Repayments at -$416624.2 in Q4 2024, -$377522.5 in Q3 2024, and -$4.1 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 23.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 216,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 19.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -416,624.20 |
| Dec 31, 2024 | -416,624.20 |
| Sep 30, 2024 | -377,522.51 |
| Sep 30, 2024 | -377,522.51 |
| Jun 30, 2024 | -4.09 Mn |
| Jun 30, 2024 | -4.09 Mn |
| Dec 31, 2023 | -16.56 Mn |
| Dec 31, 2023 | -16.56 Mn |
| Sep 30, 2023 | -384,900.12 |
| Sep 30, 2023 | -384,900.12 |
| Dec 31, 2022 | -94.82 Mn |
| Dec 31, 2022 | -94.82 Mn |
| Sep 30, 2022 | -111.68 Mn |
| Sep 30, 2022 | -111.68 Mn |
| Jun 30, 2022 | -114.24 Mn |
| Jun 30, 2022 | -114.24 Mn |
| Mar 31, 2022 | -9.09 Mn |
| Mar 31, 2022 | -9.09 Mn |
| Mar 31, 2019 | -7.55 Mn |
| Mar 31, 2019 | -7.55 Mn |